The HMG-CoA reductase inhibitor, atorvastatin, attenuates the effects of acute administration of amyloid-β1–42 in the rat hippocampus in vivo
- 21 August 2006
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 52 (1) , 136-145
- https://doi.org/10.1016/j.neuropharm.2006.07.031
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Regulation of microglial activities by glial cell line derived neurotrophic factorJournal of Cellular Biochemistry, 2005
- Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanismProgress in Neurobiology, 2005
- 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors Attenuate β-Amyloid-Induced Microglial Inflammatory ResponsesJournal of Neuroscience, 2005
- Soluble Arctic amyloid β protein inhibits hippocampal long‐term potentiation in vivoEuropean Journal of Neuroscience, 2004
- The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune diseaseNature, 2002
- Alzheimer Amyloid β-Peptide Inhibits the Late Phase of Long-Term Potentiation through Calcineurin-Dependent Mechanisms in the Hippocampal Dentate GyrusNeurobiology of Learning and Memory, 2002
- Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivoNature, 2002
- The B7 Family of Ligands and Its Receptors: New Pathways for Costimulation and Inhibition of Immune ResponsesAnnual Review of Immunology, 2002
- SB203580, the p38 mitogen-activated protein kinase inhibitor blocks the inhibitory effect of β-amyloid on long-term potentiation in the rat hippocampusNeuroscience Letters, 2000
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976